Cefotaxime

Product NDC: 64679-947
11-digit product format: 646790947
Labeler code: 64679
Product ID: 64679-947_4d51bfa3-dadf-44bc-a2b6-75f477945341
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cefotaxime
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAMUSCULAR; INTRAVENOUS
Labeler: Wockhardt USA LLC.
Application: ANDA065197
Marketing category: ANDA
Marketing start: 2008-06-20
Marketing end: 0000-00-00
Substance: CEFOTAXIME SODIUM
Active strength: 500 mg/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	64679-947		I	Inactivated by FDA	2026-10-05
excluded package	package	64679-947	64679-947-01	I	Inactivated by FDA	2026-10-05
excluded package	package	64679-947	64679-947-02	I	Inactivated by FDA	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 57 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64679-947-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64679-947-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64679-947-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64679-947-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64679-947-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64679-947-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64679-947-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64679-947-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64679-947-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64679-947-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64679-947-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64679-947-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64679-947-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64679-947-02	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	64679-947-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	64679-947-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	64679-947-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	64679-947-02	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	64679-947-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	64679-947-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	64679-947-01	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	64679-947-02	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	64679-947-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	64679-947-02	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	64679-947-01	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	64679-947-02	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	64679-947-01	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	64679-947-02	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	64679-947-01	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	64679-947-02	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	64679-947-01	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	64679-947-02	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	64679-947-01	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	64679-947-02	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	64679-947-01	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	64679-947-02	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	64679-947-01	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	64679-947-02	`8dfbde2a14a4…`	`c9ff85d89658…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A065197-001	CEFOTAXIME	CEFOTAXIME SODIUM	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	2006-08-29
A065197-002	CEFOTAXIME SODIUM	CEFOTAXIME SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	2008-06-20
A065197-003	CEFOTAXIME SODIUM	CEFOTAXIME SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	2008-06-20

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A065197-001	CEFOTAXIME	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	2006-08-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A065197-002	CEFOTAXIME SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A065197-003	CEFOTAXIME SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A065197-001	CEFOTAXIME	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	2006-08-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065197-002	CEFOTAXIME SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065197-003	CEFOTAXIME SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065197-001	CEFOTAXIME	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	2006-08-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065197-002	CEFOTAXIME SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065197-003	CEFOTAXIME SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065197-001	CEFOTAXIME	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	2006-08-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065197-002	CEFOTAXIME SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065197-003	CEFOTAXIME SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065197-001	CEFOTAXIME	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	2006-08-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065197-002	CEFOTAXIME SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065197-003	CEFOTAXIME SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065197-001	CEFOTAXIME	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	2006-08-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065197-002	CEFOTAXIME SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065197-003	CEFOTAXIME SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065197-001	CEFOTAXIME	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	2006-08-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065197-002	CEFOTAXIME SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065197-003	CEFOTAXIME SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065197-001	CEFOTAXIME	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	2006-08-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065197-002	CEFOTAXIME SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065197-003	CEFOTAXIME SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065197-001	CEFOTAXIME	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	2006-08-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065197-002	CEFOTAXIME SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065197-003	CEFOTAXIME SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065197-001	CEFOTAXIME	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	2006-08-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065197-002	CEFOTAXIME SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065197-003	CEFOTAXIME SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065197-001	CEFOTAXIME	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	2006-08-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065197-002	CEFOTAXIME SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065197-003	CEFOTAXIME SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065197-001	CEFOTAXIME	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	2006-08-29	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065197-002	CEFOTAXIME SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065197-003	CEFOTAXIME SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065197-001	CEFOTAXIME	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	2006-08-29	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065197-002	CEFOTAXIME SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065197-003	CEFOTAXIME SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	2008-06-20	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065197-001	CEFOTAXIME	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	2006-08-29	`301d65b070ca…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A065197-001	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065197-002	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065197-003	AP	1	`74a2ff9319b5…`
2019-09-15 20:21 UTC	2019-09	A065197-001	AP	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A065197-002	AP	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A065197-003	AP	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065197-001	AP	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A065197-002	AP	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A065197-003	AP	1	`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
240c5dde-7ad4-44da-afce-de9486640146	Product name	2	20160328

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
64679-947-01	2021-01-29	C162847	48780-1	ba0f9c33-2bba-a910-e053-dadaa90a0b85	Prescribing information Cefotaxime for Injection, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefotaxime for injection and other antibacterial drugs, cefotaxime for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
64679-947-02	2021-01-29	C162847	48780-1	ba0f9c33-2bba-a910-e053-dadaa90a0b85	Prescribing information Cefotaxime for Injection, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefotaxime for injection and other antibacterial drugs, cefotaxime for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
64679-947-01	Cefotaxime	1 in 1 CARTON	INJECTION, POWDER, FOR SOLUTION	1	4
64679-947-02	Cefotaxime	10 in 1 CARTON	INJECTION, POWDER, FOR SOLUTION	10	4
64679-947-02	Cefotaxime	1 in 1 CARTON	INJECTION, POWDER, FOR SOLUTION	1	4

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version	Uploaded
CEFOTAXIME SODIUM	ACTIVE INGREDIENT	258J72S7TZ	CEFOTAXIME INJECTION, POWDER, FOR SOLUTION [WOCKHARDT USA LLC.]	1
CEFOTAXIME	ACTIVE MOIETY	N2GI8B1GK7	CEFOTAXIME INJECTION, POWDER, FOR SOLUTION [WOCKHARDT USA LLC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
64679-947	CEFOTAXIME INJECTION, POWDER, FOR SOLUTION [WOCKHARDT USA LLC.]	4	Legacy NDC, 3 package rows	20200125_f3c5895f-f54b-43d4-9b38-7bfbdf8335b7.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
258J72S7TZ	CEFOTAXIME SODIUM	64485-93-4	CEFOTAXIME SODIUM
N2GI8B1GK7	CEFOTAXIME	63527-52-6	Cefotaxime

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1656313	cefotaxime 1 GM Injection	PSN	f3c5895f-f54b-43d4-9b38-7bfbdf8335b7	4
1656318	cefotaxime 2 GM Injection	PSN	f3c5895f-f54b-43d4-9b38-7bfbdf8335b7	4
309068	cefotaxime 500 MG Injection	PSN	f3c5895f-f54b-43d4-9b38-7bfbdf8335b7	4
1656313	cefotaxime 1000 MG Injection	SCD	f3c5895f-f54b-43d4-9b38-7bfbdf8335b7	4
1656318	cefotaxime 2000 MG Injection	SCD	f3c5895f-f54b-43d4-9b38-7bfbdf8335b7	4
309068	cefotaxime 500 MG Injection	SCD	f3c5895f-f54b-43d4-9b38-7bfbdf8335b7	4
1656313	cefotaxime (as cefotaxime sodium) 1 GM Injection	SY	f3c5895f-f54b-43d4-9b38-7bfbdf8335b7	4
1656318	cefotaxime (as cefotaxime sodium) 2 GM Injection	SY	f3c5895f-f54b-43d4-9b38-7bfbdf8335b7	4
309068	cefotaxime (as cefotaxime sodium) 500 MG Injection	SY	f3c5895f-f54b-43d4-9b38-7bfbdf8335b7	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
64679-947-01	64679094701	1 in 1 CARTON	Historical
64679-947-02	64679094702	10 in 1 CARTON	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cefotaxime - Wockhardt USA LLC. \| Wockhardt Limited	Wockhardt USA LLC. \| Wockhardt Limited	2019-11-26	HUMAN PRESCRIPTION DRUG LABEL	4